Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients.
about
Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionCancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells.Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer.Circulating Tumor Cells as Cancer Biomarkers in the Clinic.PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.Biology and clinical significance of circulating tumor cell subpopulations in lung cancerA preliminary study for the assessment of PD-L1 and PD-L2 on circulating tumor cells by microfluidic-based chipcytometry.LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice.Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer.Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells.Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis.In wound repair vimentin mediates the transition of mesenchymal leader cells to a myofibroblast phenotype.Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy.Circulating tumor cells in clinical research and monitoring patients with colorectal cancer.Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer.
P2860
Q28066285-0E1D9AA1-7E2A-4119-A7B8-04FC9359E103Q33869749-803CED20-BC38-4684-A0E3-C2F7801DDACAQ36356608-33A175EC-B5AF-483D-B526-13BA64FC6AD4Q38740295-354896E8-4985-4476-9E7A-42857F4FA394Q39339875-33A89757-0430-4B4C-8384-FEFF2E9D2DEAQ40160069-37BD743D-56E5-4D17-99CC-4AE46B09D75BQ41605032-FA181899-7CDA-4AD6-BA99-A28DD1EA8786Q47104764-E31E7C11-6969-41A6-A495-6D17609CCB61Q47222619-56BC7B65-7EAF-4CCF-943B-43E82A8F646AQ50042048-49CB64CF-AA95-4215-9696-541D142BBC3BQ50129978-9636A3F1-189A-4223-886F-FE30B565290FQ50199981-5CD2DB06-15E6-41B5-9272-13B7E774170EQ50433337-ED78F9AE-1180-4C0E-B5EF-4B39F35C4B91Q50559927-32A0C166-09D2-48AE-9632-CA10532BF7FEQ52767819-D57F106D-80E4-4999-B57D-1B60C8BC30C9Q54284559-C548BFB9-B193-4E7B-8680-784CB2A7DDC7Q55071620-222C8FCE-1509-41C1-85EC-A91915C4E2F3Q55117076-D27DD3B6-9D72-4910-ABAC-143F371C6BBBQ55343494-B048B774-110E-40E4-A56E-EDEBC50CFEBB
P2860
Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Potential role of nuclear PD-L ...... tic marker in cancer patients.
@en
Potential role of nuclear PD-L ...... tic marker in cancer patients.
@nl
type
label
Potential role of nuclear PD-L ...... tic marker in cancer patients.
@en
Potential role of nuclear PD-L ...... tic marker in cancer patients.
@nl
prefLabel
Potential role of nuclear PD-L ...... tic marker in cancer patients.
@en
Potential role of nuclear PD-L ...... tic marker in cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Potential role of nuclear PD-L ...... stic marker in cancer patients
@en
P2093
Arun Satelli
Christina Rojas
Izhar Singh Batth
Qing H Meng
Zachary Brownlee
P2860
P2888
P356
10.1038/SREP28910
P407
P50
P577
2016-07-01T00:00:00Z